Lowering the risk of Parkinson's disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2020
published in
- Brain : a journal of neurology Journal